News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
PhRMA Lobby Names Corporate Heavyweight John Castellani As Chief
July 14, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, July 13 (Reuters) - The U.S. drug industry named a top corporate lobbyist on Tuesday to head its trade association, a move that analysts said could mean a tougher approach on healthcare issues by big pharma.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Podcast
Novartis’ Zolgensma woes, BIO’s China plan, GLP-1s’ new safety warning, FDA’s stacked November
November 11, 2026
·
2 min read
·
Jef Akst
Layoffs
Coherus cuts 30% of staffers, Gyre makes post-acquisition layoffs
November 10, 2026
·
2 min read
·
Gabrielle Masson
China
BIO pitches US plan to beat China in biotech ‘space race’
November 10, 2026
·
2 min read
·
Annalee Armstrong
Approvals
Bayer wins first-in-class FDA nod for blood thinner, setting stage for BMS-J&J rival
November 10, 2026
·
2 min read
·
Gabrielle Masson